Notable healthcare headlines for the week: J&J, Pfizer, and Novo Nordisk in focus [Seeking Alpha]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Seeking Alpha
The blue-chip Dow Jones Industrial Average slipped to 48,710.97 points, while the benchmark S&P 500 fell to 6,929.94 Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights FDA approval boosted Novo shares and may increase competition with Eli Lilly in the weight loss drug segment as both firms vie for a sizable market opportunity, with analysts projecting oral drugs could reach 25% of the $150B market. Johnson & Johnson faces a record $1.5 billion verdict in a talc cancer case, the largest single-plaintiff sum, though J&J intends to appeal. Trump's efforts to reschedule marijuana boosted cannabis stocks, as reclassification could facilitate broader market growth and inclusion with less restrictive drugs under Schedule III. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapiesBusiness Wire
- JonesTrading Highlights Differentiated Pipeline at Atai Beckley N.V. (ATAI) [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson Terminates Trial of Atopic Dermatitis Drug Candidate [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson halts mid-stage trial of experimental eczema drug [CNBC]CNBC
JNJ
Earnings
- 10/14/25 - Beat
JNJ
Sec Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- JNJ's page on the SEC website